Farenax Tablets – Triple-Strength Antimalarial Therapy
Farenax is a highly effective antimalarial medicine combining three active agents: **Artesunate (200mg), Sulfadoxine (500mg), and Pyrimethamine (25mg)**. This triple-action formula is designed to treat uncomplicated malaria caused by Plasmodium falciparum, especially in areas with drug-resistant strains. Farenax delivers fast-acting relief and long-lasting protection in one powerful combination.
Product Details
- Brand: Farenax
- Strength per Tablet: Artesunate 200 mg + Sulfadoxine 500 mg + Pyrimethamine 25 mg
- Pack Size: 6 tablets
- Form: Oral tablets
- Therapeutic Class: Artemisinin-based combination therapy (ACT)
Composition & Ingredients
Each tablet contains:
- Artesunate – 200 mg
- Sulfadoxine – 500 mg
- Pyrimethamine – 25 mg
Inactive Ingredients may include: Lactose, maize starch, magnesium stearate, microcrystalline cellulose.
Uses and Indications
Farenax is used for:
- Treatment of uncomplicated malaria due to Plasmodium falciparum
- Recommended in malaria-endemic regions with known drug resistance
Key Benefits
- Triple combination therapy improves treatment success and reduces resistance
- Artesunate ensures rapid clearance of malaria parasites and fast symptom relief
- Sulfadoxine and pyrimethamine provide long-lasting suppression of parasite regrowth
- Convenient 6-tablet course ensures adherence and full therapeutic effect
How to Use
Use strictly as directed by a healthcare professional. The standard regimen involves dosing over a 3-day treatment period. Tablets should be taken with food and water to enhance absorption and minimize gastrointestinal side effects. Do not miss doses or stop early, even if symptoms improve.